Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2005-09-20
2005-09-20
Maier, Leigh C. (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C514S054000, C514S061000, C514S062000
Reexamination Certificate
active
06946451
ABSTRACT:
Provided are a method for promoting insulin secretion, a method for suppressing the elevation of a blood glucose level, a method for ameliorating diabetes mellitus, a method for promoting growth of an animal, and a method for increasing an insulin level in breast milk. These methods comprising administering at least one member selected from the group consisting of a di- or a higher saccharide containing galactose, a derivative thereof, a saccharide containing N-acetylneuraminic acid, and a derivative thereof, to a patient in need thereof or an animal.
REFERENCES:
patent: 4122188 (1978-10-01), Stacpoole
patent: 4705687 (1987-11-01), Lau
patent: 5002759 (1991-03-01), Gaffar et al.
patent: 5164374 (1992-11-01), Rademacher et al.
patent: 5177062 (1993-01-01), Miyata et al.
patent: 5260280 (1993-11-01), Isoda et al.
patent: 5401723 (1995-03-01), Gaffar et al.
patent: 5468734 (1995-11-01), Seri et al.
patent: 5514660 (1996-05-01), Zopf et al.
patent: 5639734 (1997-06-01), Esko et al.
patent: 6083934 (2000-07-01), Prieto et al.
patent: 6596707 (2003-07-01), Leach et al.
patent: 6777397 (2004-08-01), Zehner et al.
patent: 197 01 382 (1998-07-01), None
patent: 0 313 533 (1988-10-01), None
patent: 0 473 108 (1992-03-01), None
patent: 99/56754 (1999-11-01), None
patent: 00/32205 (2000-06-01), None
patent: 01/43751 (2001-06-01), None
patent: 01/78748 (2001-10-01), None
“Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus”,Diabetes Care, vol. 20, No. 7 (1997), pp. 1183-1197.
Tritos, et al., “Syndromes of Severe Insulin Resistance”,Journal of Clinical Endocrinology and Metabolism, vol. 83, No. 9 (1998), pp. 3025-3030.
Cevreska, et al., The Presence of Immunologically Reactive Insulin in Milk of Woman . . . , God. Zb. Med. Fak. Skopje, vol. 21 (1975), pp. 35-41.
Ukkonen, et al., “Treatment of acute otitis media with an antiadhesive oligosaccharide: a randomised, double-blind, placebo-controlled trial”,The Lancet, vol. 356 (2000), pp. 1398-1402.
Endo Tetsuo
Kamiya Toshikazu
Koizumi Satoshi
Takada Miho
Fitzpatrick ,Cella, Harper & Scinto
Kyowa Hakko Kogyo Co. Ltd.
Maier Leigh C.
LandOfFree
Insulin secretion promoter does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Insulin secretion promoter, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Insulin secretion promoter will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3378124